Coronary artery disease
Conditions
Interventions
Case series:Implantation of Absorbable Metal Stent (AMS) consisting magnesium alloy (Magmaris), 1.4 microgram/mm2 for 12 months
Sponsors
Department of Medicine & Therapeutics, The Chinese University of Hong Kong
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Subject is =18 years of age; 2. Subject received Magmaris implantation in Prince of Wale Hospital within 12 months before enrollment; 3. Subject has provided written informed consent.
Exclusion criteria
Exclusion criteria: Subject's physical condition which is contraindicated for coronary angiography
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stent strut coverage; | — |
Secondary
| Measure | Time frame |
|---|---|
| OCT derived percentage stent strut malapposition immediately post-intervention;OCT derived ratio of uncovered to total stent struts per section >30%;OCT derived stent area(circumferential area limited by the contours of the struts), lumen area(circumferential dark zone in the center of the struts), neointimal area(calculated by subtracting the lumen area from the stent area) & neointimal thickness(distance between surface of each stent & lumen);Comparison of the stent strut coverage and malapposition rate with OCT between acute coronary syndrome an stable angina;Comparison of the stent strut coverage and malapposition rate with OCT between Magmaris and other drug eluting stent/bare metal stents;Incidence of target lesion failure [TLF, composite of cardiac death, non-fatal myocardial infarction (MI) or target lesion revascularization (TLR) (by PCI or by coronary artery bypass grafting)]; | — |
Countries
China
Contacts
Public ContactProf. Bryan Yan
Division of Cardiology, Dept. of Medicine and Therapeutics
Outcome results
None listed